GlaxoSmithKline Pharmaceuticals Limited

NSE GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2024: USD 69.78 M

GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow is USD 69.78 M for the year ending March 31, 2024, a 18.44% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2023 was USD 58.92 M, a -44.82% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2022 was USD 106.78 M, a 35.28% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2021 was USD 78.93 M, a 21.26% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2020 was USD 65.09 M, a 13.26% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

NSE: GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

CEO	Mr. Bhushan Akshikar
IPO Date	July 1, 2002
Location	India
Headquarters	GSK House
Employees	3,211
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Key trends

Past 5 years